¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ(KMDS) 2024 Ãá°èº¸¼ö±³À° (2ÀÏÂ÷) : 2024-04-14

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ(KMDS) 2024 Ãá°èº¸¼ö±³À° (2ÀÏÂ÷) : 2024-04-14
±³À°ÀÏÀÚ : 2024-04-14
±³À°Àå¼Ò : »ïÁ¤È£ÅÚ ¶óº¥´õȦ

±³À°ÁÖÁ¦ : ´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ(KMDS) 2024 Ãá°èº¸¼ö±³À° (2ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇÑÆÄŲ½¼º´¹×ÀÌ»ó¿îµ¿ÁúȯÇÐȸ
´ã´çÀÚ : Ãֹ̼Ò
¿¬¶ôó : 02-6395-2876  

À̸ÞÀÏ : movement@kmds.or.kr

±³À°Á¾·ù : ½Å°æ°ú

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 50ºÐ

¼¼ºÎ¼ö°­·á : 120,000¿ø  

ºñ°í »çÀüµî·Ï(Á¤È¸¿ø 50,000¿ø, ÁØȸ¿ø 30,000¿ø, ºñȸ¿ø Àü¹®ÀÇ 100,000¿ø, ºñȸ¿ø Àü°øÀÇ 40,000¿ø) ÇöÀåµî·Ï(Á¤È¸¿ø 60,000¿ø, ÁØȸ¿ø 40,000¿ø, ºñȸ¿ø Àü¹®ÀÇ 120,000¿ø, ºñȸ¿ø Àü°øÀÇ 50,000¿ø)


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±âŸ 04¿ù 14ÀÏ »ïÁ¤È£ÅÚ ¶óº¥´õȦ 09:00~10:40 Session 1. Diagnosis and Management of Miscellaneous Movement Disorders °­¼®À±(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 04¿ù 14ÀÏ »ïÁ¤È£ÅÚ ¶óº¥´õȦ 09:00~09:30 Movement Disorders in In-patient & Emergency Settings ¹Úµ¿±Ô(¾ÆÁÖÀÇ´ë)

±³À°½Ã°£ 04¿ù 14ÀÏ »ïÁ¤È£ÅÚ ¶óº¥´õȦ 09:30~10:00 Diagnosis and Management of Tardive Syndromes ¹é°æ¿ø(°í·ÁÀÇ´ë)

±³À°½Ã°£ 04¿ù 14ÀÏ »ïÁ¤È£ÅÚ ¶óº¥´õȦ 10:00~10:30 Functional Movement Disorders ¹ÚÁ¤ÀÌ(µ¿±¹ÀÇ´ë)

Åä·Ð 04¿ù 14ÀÏ »ïÁ¤È£ÅÚ ¶óº¥´õȦ 10:30~10:40 Q&A °­¼®À±(ÇѸ²ÀÇ´ë)

±âŸ 04¿ù 14ÀÏ »ïÁ¤È£ÅÚ ¶óº¥´õȦ 10:50~12:10 Session 2. Lessons from Historic Clinical Trials ¹ÚÁ¤È£(¼øõÇâÀÇ´ë)

±³À°½Ã°£ 04¿ù 14ÀÏ »ïÁ¤È£ÅÚ ¶óº¥´õȦ 10:50~11:30 Levodopa and Dopamine Agonists À¯´Þ¶ó(°æÈñÀÇ´ë)

±³À°½Ã°£ 04¿ù 14ÀÏ »ïÁ¤È£ÅÚ ¶óº¥´õȦ 11:30~12:10 MAO-B Inhibitors and COMT Inhibitors Á¤¼®Á¾(¿¬¼¼ÀÇ´ë)

±âŸ 04¿ù 14ÀÏ »ïÁ¤È£ÅÚ ¶óº¥´õȦ 12:10~13:00 Session 3. Case-based Learning - Panels Discussion Á¶¼º¾ç(¿ï»êÀÇ´ë)

Åä·Ð 04¿ù 14ÀÏ »ïÁ¤È£ÅÚ ¶óº¥´õȦ 12:10~13:00 How to Optimize the Dopaminergic Treatment of Parkinson¡¯s Disease? °í¼º¹ü/¹ÚÁ¤È£/À¯´Þ¶ó/Á¤¼®Á¾(°í·ÁÀÇ´ë/¼øõÇâÀÇ´ë/°æÈñÀÇ´ë/¿¬¼¼ÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ(KMDS) 2024 Ãá°èº¸¼ö±³À° (2ÀÏÂ÷) : 2024-04-14""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ)2024³â Á¦8Â÷ ´ëÇѼö¸éÈ£ÈíÇÐȸ ¼ö¸é´Ù¿ø°Ë»ç ±âº»±³À°°­Á : 2024-04-14
´ÙÀ½±Û ´ëÇѾ๰¿µ¾çÀÇÇÐȸ 2024³â ±¤ÁÖÇмú´ëȸ : 2024-04-14
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20679 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦2Â÷¿¬¼ö±³À°(Ç÷°üÁúȯ, À̽ļö¼ú) : 2024-06-13 0 1 2024-05-10
20678 ¼­¿ï ±¸·Î±¸ÀÇ»çȸ 2024³âµµ Á¦2Â÷ ¿¬¼ö±³À° : 2024-06-11 0 1 2024-05-10
20677 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-06-10 0 4 2024-05-10
20676 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼ÒÈ­±â³»°ú ºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2024-06-09 0 4 2024-05-10
20675 Ãæ³² 2024³â »ó¹Ý±â ´ëÇÑÁßȯÀÚÀÇÇÐȸ ´ëÀü¼¼Á¾ÃæûÁöȸ ¿¬¼ö±³À° : 2024-06-08 0 1 2024-05-10
20674 ºÎ»ê 2024³â Á¦ 7ȸ ´ëÇÑÁßȯÀÚÀÇÇÐȸ ºÎ¿ï°æÁöȸ ¿¬¼ö°­Á : 2024-06-08 0 1 2024-05-10
20673 ´ë±¸ Á¦24Â÷ ´ë±¸°æºÏ ´ç´¢º´ ±³À°ÀÚ ¿¬¼ö°­Á : 2024-06-08 0 2 2024-05-10
20672 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 1Â÷ : 2024-06-08 0 1 2024-05-10
20671 ¼­¿ï »ï¼º¼­¿ïº´¿ø ÈäºÎ¿Ü°ú SMC MCS Symposium 2024 : 2024-06-08 0 1 2024-05-10
20670 ¼­¿ï 2024 ´ëÇѵðÁöÅÐÀÓ»óÀÇÇÐȸ ÇÏ°è Çмú´ëȸ : 2024-06-02 0 1 2024-05-10
20669 ¼­¿ï Á¦6ȸ ´ëÇѼö¼úÁ߽Űæ°è°¨½ÃÇÐȸ ¿¬¼ö°­Á : 2024-06-01 0 1 2024-05-10
20668 ºÎ»ê ±¸Á¶½ÉÁúȯ¿¬±¸È¸ The 7th K-SCI(Korea Structural Cardiovascular Intervention) Symposium : 2024-06-01 0 1 2024-05-10
20667 ±¤ÁÖ ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ 2024³â ÇÁ·ÎÆ÷Æú ÁøÁ¤±³À° : 2024-06-01 0 2 2024-05-10
20666 ´ëÀü 2024³â ´ëÇÑ°¡Á¤ÀÇÇÐȸ ´ëÀü¼¼Á¾Áöȸ Ãá°èÇмú´ëȸ(°íÇ÷¾Ð, °ú¹Î¼º ÀåÁõÈıº, ¼ö¸éÀå¾Ö) : 2024-05-30 0 2 2024-05-10
20665 °æ±â ÇѸ²´ëÇб³¼º½Éº´¿ø ºñ´¢ÀÇÇаú ¿¬¼ö°­Á : 2024-05-30 0 1 2024-05-10
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷